N4 Pharma was formed in 2014 by Nigel Theobald, the former Chief Executive of AIM quoted Oxford Pharmascience Group plc. N4 Pharma is a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance.
N4 Pharma’s reformulation work falls under two divisions:
1.generic, already commercialised, drugs; and
2.delivery of novel and existing vaccines.
N4 Pharma has identified a number of established drugs that its directors believe could be improved upon through its reformulation techniques.